baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ANGES, INC./ JP3127700007 /

2024-04-24 9:50:00 PM	Chg. -0.0040	Volume	Bid7:29:42 AM	Ask7:29:42 AM	High	Low
0.2360EUR	-1.67%	0 Turnover: 0.0000	0.2440Bid Size: 1,000	0.3480Ask Size: 1,000	0.2380	0.2360

GlobeNewswire 02-07 Artios Pharma Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Fi...

GlobeNewswire 2021-09-23 Brilliant Matters announces Strategic Investment to Accelerate Production of their High-Performing, ...

GlobeNewswire 2021-05-03 Excision BioTherapeutics Appoints Seasoned Finance Executive Christine Silverstein as Chief Financia...

GlobeNewswire 2021-04-16 Brickell Biotech Announces Presentation of US Phase 3 Open-Label Long-Term Safety Study Results for ...

GlobeNewswire 2021-03-09 Brickell Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate ...

GlobeNewswire 2020-11-18 Brickell Biotech Announces Launch Date for Sofpironium Bromide Gel, 5% (ECCLOCK®) in Japan by its De...

GlobeNewswire 2020-11-12 Brickell Biotech Reports Third Quarter 2020 Financial Results and Provides Corporate Update

GlobeNewswire 2020-09-23 Innovator ETFs Announces Upside Cap Ranges for October Series of Defined Outcome ETFs

GlobeNewswire 2020-09-08 AnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA Vac...

TeleTrader 2020-05-26 Dow futures surge 500 pts as COVID-19 worries ease

TeleTrader 2020-05-25 AnGes may release COVID-19 vaccine by year end - report

GlobeNewswire 2019-10-10 Worldwide DNA Read, Write & Edit Markets to 2024 | Technologies, Applications, Innovations, Patents,...

GlobeNewswire 2019-05-23 Global Infectious Vaccines Partnering Deal Trends, Players and Financials 2019 - Access to Over 250 ...

GlobeNewswire 2019-04-18 KALLELSE TILL ÅRSSTÄMMA I LIDDS AB (publ)

GlobeNewswire 2019-04-05 AnGes Obtains Conditional Approval in Japan for HGF Gene Therapy to Treat Critical Limb Ischemia

GlobeNewswire 2019-03-08 Global Coronary Artery Disease (CAD) Therapeutics Report 2019

GlobeNewswire 2018-12-17 Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...

GlobeNewswire 2018-09-27 Global Genetic Modification Therapies Clinical Applications Market to 2023

GlobeNewswire 2018-08-13 Gene Therapy Market, 2018-2030 - Around 300 Product Candidates Under Various Stages of Development f...

GlobeNewswire 2018-07-31 Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreem...

GlobeNewswire 2018-07-11 Global Peripheral Arterial Disease (PAD) Therapeutics 2018: Worldwide Strategic Business Report - Xa...

GlobeNewswire 2018-06-28 Daniel Crépeau Joins Fresche Solutions as Chief Operating Officer

GlobeNewswire 2018-06-26 Global Autoinjectors Market 2018-2030

GlobeNewswire 2018-05-16 Gene Therapy Market, 2030

ANGES, INC./ JP3127700007 /

If you wish to receive reply to your feedback, please provide your email address.